Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
AI-aided Precision Medicine against COVID-19: Strategic Areas of Research and Development
Enrico Santus;
Nicola Marino;
Davide Cirillo;
Emmanuele Chersoni;
Arnau Montagud;
Antonella Santuccione Chada;
Alfonso Valencia;
Kevin Hughes;
Charlotta Lindvall
ABSTRACT
Modern Artificial Intelligence (AI) technologies can play a key role in preventing and monitoring the present and the future epidemics. Here, we provide an overview of recently published literature on the COVID-19 pandemics in four strategic areas: (1) triage, diagnosis and risk prediction; (2) drug repurposing and development; (3) pharmacogenomics and vaccines; (4) mining of medical literature. In accordance to the newly proposed value-based care paradigm, we notice that AI-powered healthcare is essential to make public health systems able to efficiently handle future outbreaks and improve patient outcomes.
Citation
Please cite as:
Santus E, Marino N, Cirillo D, Chersoni E, Montagud A, Santuccione Chada A, Valencia A, Hughes K, Lindvall C
Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development